[ Price : $8.95]
Federal Register notice: FDA updates its listing of guidance documents related to the Covid-19 public health emergency.[ Price : $8.95]
FDA approves AbbVies Dalvance (dalbavancin) for treating acute bacterial skin and skin structure infections in pediatric patients....[ Price : $8.95]
Federal Register notice: FDA seeks comments about abuse potential, actual abuse, medical usefulness, trafficking, and impact of sc...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Field Alert Report Submission: Questions and Answers.[ Price : $8.95]
FDA classifies as Class 1 a Philips Respironics recall of its continuous and non-continuous ventilators due to concerns about the ...[ Price : $8.95]
FDA approves AstraZenecas Bydureon and Bydureon BCise (exenatide extended-release) injection for use in addition to diet and exerc...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Prescription Drug Advertising--21 CFR Part ...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Medical Product Communications That Are Con...